TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence
Phase 4
Completed
- Conditions
- Stress Urinary Incontinence
- Registration Number
- NCT01095159
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
This is a prospective, comparative randomized controled trial. The general purposes of this study is to compare the efficacy and safety of TVTO™ and TVTSecur™ as surgical treatment for female urinary stress incontinence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 124
Inclusion Criteria
- Clinical and urodynamic for stress urinary
Exclusion Criteria
- Detrusor overactivity (urodynamic study)
- Urodynamic changes suggesting reduced vesical capacity
- Associated neurological diseases
- Coagulopathies
- Pregnancy
- Foreign matter sensitiveness history
- Acute urinary tract infection
- Sequel from high ionizing radiation exposure
- Use of drugs that may result in high surgical risk and/or significant postoperative complication
- Anesthetic procedure contraindication
- Vulvovaginitis: presence of vaginal secretion with infection clinically or lab supported
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Compare the efficacy of employing the Gynecare TVT Secur™ with the traditional Gynecare TVT- O™ for treating female stress urinary incontinence. 1 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which TVTO and TVTS devices address stress urinary incontinence in women?
How does the efficacy of TVTO compare to standard-of-care surgical treatments for female stress urinary incontinence?
Are there specific biomarkers that can predict optimal patient selection for TVTO or TVTS procedures?
What are the long-term adverse event profiles associated with TVTO and TVTS in phase 4 trials?
How do TVTO and TVTS compare to other transvaginal mesh devices in treating stress urinary incontinence?
Trial Locations
- Locations (1)
Federal University of Sao Paulo - Unifesp
🇧🇷São Paulo, SP, Brazil
Federal University of Sao Paulo - Unifesp🇧🇷São Paulo, SP, Brazil